Tellus BioVentures is a life sciences investment fund focused on early-stage innovation and company formation.
Tellus was founded in 2019 to uncover and accelerate promising life science innovation, enable talented entrepreneurs and scientists, and serve patients with unmet needs.
We make select early investments at the Seed stage in private biotech ventures as the lead or sole investor and participate in Series-A investments.
We launch and fund de novo companies to advance important innovations, which may otherwise lack the proper resources to progress and thrive.
People
- Heidi Kempinski, Senior Principal
You last contacted this investor on .